Sign in

CIK 0000899923

  • Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870494517
Phone
+1 801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$34,252
in 1 filing

Net −$34,252. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Davis Mark Steven −$34K Director sold 6% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-01-22 King Gary A. Exec. VP International Ops Exercise or conversion +30,000 $19.47 $584K 151,968
2018-01-22 King Gary A. Exec. VP International Ops Sale −30,000 $39.77 $1.2M 121,968
2018-01-22 King Gary A. Exec. VP International Ops Exercise or conversion +4,445 $18.00 $80K 126,413
2018-01-22 King Gary A. Exec. VP International Ops Sale −4,445 $39.03 $173K 121,968
2018-01-22 King Gary A. Exec. VP International Ops Exercise or conversion · Non-Qualified Stock Option (right to buy) −4,445 0
2018-01-22 King Gary A. Exec. VP International Ops Exercise or conversion · Non-Qualified Stock Option (right to buy) −30,000 27,432
2018-01-22 MARSH RICHARD M E.V.P., General Counsel Exercise or conversion +37,654 $30.12 $1.1M 157,648
2018-01-22 MARSH RICHARD M E.V.P., General Counsel Sale −37,654 $40.25 $1.5M 119,994
2018-01-22 MARSH RICHARD M E.V.P., General Counsel Exercise or conversion +3,775 $26.49 $100K 123,769
2018-01-22 MARSH RICHARD M E.V.P., General Counsel Exercise or conversion · Incentive Stock Option (right to buy) −3,775 0
2018-01-22 MARSH RICHARD M E.V.P., General Counsel Exercise or conversion · Non-Qualified Stock Option (right to buy) −37,654 0
2018-01-18 King Gary A. Exec. VP International Ops Exercise or conversion +3,120 $14.88 $46K 125,088
2018-01-18 King Gary A. Exec. VP International Ops Sale −3,120 $38.12 $119K 121,968
2018-01-18 King Gary A. Exec. VP International Ops Exercise or conversion · Non-Qualified Stock Option (right to buy) −3,120 0
2018-01-18 MARSH RICHARD M E.V.P., General Counsel Exercise or conversion +40,000 $30.12 $1.2M 159,994
2018-01-18 MARSH RICHARD M E.V.P., General Counsel Sale −40,000 $38.25 $1.5M 119,994
2018-01-18 MARSH RICHARD M E.V.P., General Counsel Exercise or conversion · Non-Qualified Stock Option (right to buy) −40,000 37,654
2018-01-12 MARSH RICHARD M E.V.P., General Counsel Sale −13,759 $36.25 $499K 119,994
2018-01-05 MARSH RICHARD M E.V.P., General Counsel Gift −3,000 133,753
2018-01-02 Tobin Bernard President Crescendo BioScience Returned to the company −3,621 $34.91 $126K 142,551

Page 44 of 60 · 1,194 trades